background image

Paid Clinical Trials Philadelphia

Discover 2,123 paid clinical trials in Philadelphia, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Recruiting
PHASE3

Sponsor:

Alliance for Clinical Trials in Oncology

Location:

Chadds Ford, Wilmington, Newark, Elktonshow 11 more

Code:

NCT06632327

Conditions

Resectable Lung Non-Small Cell Carcinoma

Stage II Lung Cancer AJCC v8

Stage IIIA Lung Cancer AJCC v8

Stage IIIB Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Surgical Procedure

Cisplatin

Carboplatin

Pemetrexed

Gemcitabine

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting
PHASE3

Sponsor:

Pfizer

Location:

Freehold, Hershey, New York, Hanovershow 93 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Recruiting
PHASE2

Sponsor:

New York Medical College

Location:

Philadelphia, Baltimore, Columbus, Indianapolisshow 5 more

Code:

NCT03266627

Conditions

Adenovirus

Primary Immune Deficiency Disorder

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Not accepted

Interventions

cytotoxic t-lymphocytes

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Philadelphia, Voorhees, Brooklyn, Bostonshow 74 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)

Recruiting
PHASE3

Sponsor:

Rare Thyroid Therapeutics International AB

Location:

Philadelphia, Hillsborough, Atlanta, Saint Louisshow 2 more

Code:

NCT05579327

Conditions

Monocarboxylate Transporter 8 Deficiency

Allan-Herndon-Dudley Syndrome

Eligibility Criteria

Sex: Male

Age: 4+

Healthy Volunteers: Not accepted

Interventions

Tiratricol

Placebo

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Recruiting
PHASE2
PHASE3

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Location:

Cherry Hill, Allentown, New York, Cedarhurstshow 12 more

Code:

NCT05729373

Conditions

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

SEP-363856

Placebo

A Trial to Learn if Dupilumab is Safe for and Helps Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis

Recruiting
PHASE2
PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Philadelphia, New York, Great Neck, Hagerstownshow 42 more

Code:

NCT05831176

Conditions

Eosinophilic Gastritis

Eosinophilic Duodenitis

Eosinophilic Gastrointestinal Disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Dupilumab Dose 1

Dupilumab Dose 2

Matching Placebo

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Philadelphia, Wynnewood, Media, Paolishow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Recruiting

Sponsor:

NICHD Pelvic Floor Disorders Network

Location:

Philadelphia, Providence, Durham, Chicagoshow 3 more

Code:

NCT06480227

Conditions

Stress Urinary Incontinence

Urinary Incontinence

Mixed Urinary Incontinence

Eligibility Criteria

Sex: Female

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Solyx Single-incision Sling

Bulkamid Transurethral Bulking Agent

Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve

Recruiting

Sponsor:

Edwards Lifesciences

Location:

Philadelphia, New York, Pittsburgh, Durhamshow 19 more

Code:

NCT05526560

Conditions

Mitral Stenosis

Mitral Valve Insufficiency

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MITRIS RESILIA Mitral Valve, Model 11400M

Philadelphia boasts a strong healthcare network and prominent medical research centers, making it a pivotal location for a diverse range of clinical trials. Renowned institutions such as the University of Pennsylvania, Thomas Jefferson University, and Temple University lead the way in innovative research. These centers are known for their cutting-edge studies across various fields, including oncology, cardiology, neurology, and infectious diseases.

The city’s rich tapestry of clinical research is supported by its diverse population, while the collaborative research environment in Philadelphia also fosters groundbreaking discoveries that can transform patient care and improve health outcomes on a broader scale.

Why choose Philadelphia for clinical trials?

Common conditions studied in Philadelphia

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Philadelphia